Premature pubarche as a first presentation of pituitary macroprolactinoma
Journal of Research in Medical Sciences, 2020 Prolactinoma is a rare tumor of childhood. Clinical presentations of prolactinoma include amenorrhea, delayed puberty, and galactorrhea. For the first time, in this case, elevated prolactin levels were associated with unexpected premature pubarche.
Fatemeh Tabatabaei +5 more
doaj +1 more source
The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma. [PDF]
, 2004 It is well established that disruption of apoptosis may lead to tumor initiation, progression or metastasis. It is also well documented that many anticancer drugs induce apoptosis.
Gruszka, Anna +2 more
core +1 more source
Giant prolactinoma: case report and review of literature [PDF]
, 2013 “Invasive giant prolactinoma” is a large prolactinoma (>4 cm in dimension) presenting with serum prolactin levels of >1000 ng/dL and mass related clinical symptoms.
Bagher Larijani +3 more
core +2 more sources
A broader outlook is required to stage and classify pituitary neoplasms for patient care
Brain Pathology, Volume 35, Issue 1, January 2025.
Shlomo Melmed +3 more
wiley +1 more source
Frontiers in EndocrinologyPurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao +14 more
doaj +1 more source
Predictors of neuropsychiatric side effects of dopamine-agonist therapy in patients with prolactinomas [PDF]
, 2012 Background: Prolactinomas are the most frequent pituitary adenomas. The treatment with cabergoline, the most common dopamine agonist used, is associated with side effects such as nausea, vomiting, dizziness, headaches, movement disorders and fatigue ...
Athanasoulia, A.
core +1 more source
New Insights in the Management of Antipsychotics in the Treatment of Schizophrenia in a Patient with Prolactinoma: A Case Report and Review of the Literature [PDF]
, 2010 Prolactinomas are the commonest pituitary adenomas and the major pathological cause of hyperprolactinaemia. Symptomatic prolactinomas are treated mainly by dopamine agonists; surgery and radiotherapy are options for nonresponders. Schizophrenia treatment
Ary Gadelha +3 more
core +3 more sources
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
Indian Journal of Endocrinology and Metabolism, 2017 Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare +6 more
doaj +1 more source
A challenging case of prolactinoma in pregnancy [PDF]
Prolactinomas are the most common functional tumour of pituitary gland arising from lactotrophs. Microadenomas constitute 90% and the rest are macroadenomas. Females are more prone to develop macroadenomas. High estrogen levels during pregnancy leads to
Bhorania, Riddhi +3 more
core +2 more sources
Ten-year follow-up of a giant prolactinoma [PDF]
, 2015 Giant prolactinomas are rare pituitary tumours of which management can be a challenge. A 28-year-old man presented with headaches, visual impairment and behavioural changes.
Almeida, R +3 more
core +1 more source